Analyst Price Targets — MDXG
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 23, 2026 6:49 am | — | UBS | $10.00 | $5.17 | StreetInsider | Citizens Starts MiMedx Group (MDXG) at Market Outperform |
| November 15, 2024 11:48 am | Anthony Petrone | Mizuho Securities | $16.00 | $9.09 | StreetInsider | MiMedx Group (MDXG) PT Raised to $16 at Mizuho |
| July 2, 2024 6:15 am | Ross Osborn | Cantor Fitzgerald | $11.00 | $6.70 | TheFly | MiMedx initiated with an Overweight at Cantor Fitzgerald |
| April 29, 2024 8:43 am | Brooks O'Neil | Lake Street | $12.00 | $6.27 | TheFly | Proposed new LCDs likely benefit MiMedx if implemented, says Lake Street |
| September 7, 2022 6:20 am | — | H.C. Wainwright | $8.00 | $3.42 | Benzinga | HC Wainwright & Co. Maintains Buy on MiMedx Group, Lowers Price Target to $8 |
Latest News for MDXG
NEW YORK, May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MiMedx Group, Inc. ("MiMedx" or the "Company") (NASDAQ: MDXG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
MARIETTA, Ga., May 21, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the Craig-Hallum 23 rd Annual Institutional Investor Conference on Thursday, May 28, 2026 in Minneapolis, MN. Investors interested in meeting with senior management may contact their Craig-Hallum representative.
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of MiMedx Group, Inc. (“MiMedx” or the “Company”) (NASDAQ: MDXG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG PR Newswire
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MiMedx Group, Inc. ("MiMedx" or the "Company") (NASDAQ: MDXG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MDXG.
U.S. House Trading
No House trades found for MDXG.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.